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Acquired essential fatty acid depletion in the remnant kidney: Amelio-
ration with U-63557A. Previous studies have demonstrated an association
between renal cortical fatty acid composition and experimental models of
renal injury. The present study was designed to extend these observations
to the remnant kidney and to investigate the hypothesis that increased
endogenous turnover of arachidonic acid metabolites results in the
depletion of progenitor fatty acids. Remnant kidney cortex demonstrated
a relative reduction of the essential fatty acids, linoleate and arachidonate
(20 7.2% and 11 0.3%, respectively), nine weeks after subtotal
nephrectomy. In addition, the monounsaturated fatty acid, oleate, was
increased (48 10.6%) while its saturated progenitor, stearate, was
decreased (13 4.3%). Serial evaluation of dienoic prostanoids revealed
a significant increase in the renal excretion of TXB2 in rats with remnant
kidneys (27 3.0,29 1.1, and 34 3.3 ngldayvs. 21 0.8,20 1.5, and
22 3.3 nglday in control rats, at 3,6, and 9 weeks, respectively).
Moreover, TXB2 excretion inversely correlated with dienoic progenitor
fatty acids [18:2(n-6), r2 = 0.76; 20:4(n-6), r2 = 0.79], suggesting that these
events are biochemically coupled. Endogenous turnover of precursor fatty
acids, confirmed by an increase in renal TXB2 excretion, preceded overt
depletion of essential fatty acids by several weeks. Importantly, blockade
of endogenous synthesis of TXA2 with the specific TXA2 synthase
antagonist, U-63557A, restored the essential fatty acid composition to
normal and ametiorated progressive glomerutar destruction. Moreover,
the ancillary fatty acid disturbances were attenuated by administration of
U-63557A. These results are consistent with the hypothesis that uncon-
trolled endogenous synthesis of renal TXA2 deplete progenitor fatty acids
and induce compensatory alterations in other fatty acids.
The mechanisms responsible for the progression of renal injury
have been intensely investigated during the past decade [1].
However, the role of lipids has emerged as particularly intriguing
and striking analogies of glomerulosclerosis to atherosclerosis
have been noted [2], Interestingly, alterations in the renal cortical
fatty acid profile of several experimental models of renal injury
have also been described [3—61. Since phospholipid fatty acids are
precursors for prostaglandin synthesis [7], we hypothesized that
disturbances in tissue fatty acid composition were biochemically
coupled to abnormalities in prostaglandin synthesis. Although
increases in renal eicosanoid synthesis have been described in
several experimental models of progressive renal injury, we chose
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to explore our hypothesis in the remnant model of renal injury,
since renal ablation reliably increases the urinary excretion of
arachidonic acid metabolites [8] and, thus, was expected to serve
as an excellent model to study potential links between endogenous
prostaglandin synthesis and tissue fatty acid composition.
Initial studies were designed to elucidate the cortical fatty acid
composition of the remnant kidney. Having established a signifi-
cant inverse correlation between cortical essential fatty acid
depletion and renal TXA2 synthesis, additional experiments were
performed to confirm whether enhanced renal TXA2 synthesis
was directly coupled to essential fatty acid depletion. Therefore,
nephrectomized rats were placed on chronic subcutaneous infu-
sions of U-63557A, a specific antagonist of TXA2 synthase [9],
followed by determination of renal prostaglandin synthesis and
cortical fatty acid composition. The results presented herein
suggest that increased TXA2 synthesis in the remnant kidney is
coupled to polyunsaturated fatty acid disturbances in the renal
cortex.
Methods
Experimental design
Three separate studies were carried out:
Study 1. An initial investigation consisting of a long-term study
to (1) delineate the cortical fatty acid composition of the remnant
kidney and (2) investigate the relationship of cortical fatty acid
concentration to endogenous prostaglandin synthesis. Thus, in
these experiments, male Sprague-Dawley rats were randomly
allocated into two groups; control rats (N = 10) underwent sham
surgery at six weeks of age and nephrectomized rats (N = 10)
underwent infarction of ¾th of the total renal mass. Renal
infarctions were performed in anesthetized rats as previously
described [10]. All rats were fed standard laboratory chow for the
duration of the study. Rats were pair-fed and weekly body weights
were obtained in each group. At three, six and nine weeks
following surgery, rats were individually housed in metabolic
cages and 24 hour urine collections were obtained for quantitation
of TXB2 and PGE2 excretion. During the collection, rats were
allowed free access to water but were deprived access to food.
Urine was also quantitated for albumin excretion. At 15 weeks of
age (9 weeks after surgery) renal tissue was obtained for morpho-
metric studies and fatty acid determinations were carried out.
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Importantly, endogenous TXB2 excretion inversely correlated
with linoleic and arachidonic acid concentration in these studies.
Study 2. Having established an apparent biochemical link
between prostaglandin fatty acid precursor concentration and
renal TXA2 synthesis, we hypothesized that blockade of endoge-
nous renal TXA2 synthesis would ameliorate the disturbed fatty
acid profile of the remnant kidney. In these experiments male
Sprague-Dawley rats were randomly allocated into three groups;
control rats (N = 10), nephrectomized rats undergoing 5/6th
infarction of the total renal mass (N = 10), and nephrectomized
rats that were placed on chronic administration of the specific
TXA2 synthase antagonist (N = 10), U-63557A (Upjohn, Kalama-
zoo, Michigan, USA), via subcutaneous implantation of a mini-
osmotic pump (Aiza Corp., Pala Alto, California, USA). Mini-
osmotic pumps were loaded with 300 mg/cc of U-63557A to
achieve a constant infusion of drug (0.15 mg/hr X 14 days) [11,
12]. Pumps were changed every two weeks for the duration of the
experiment. Rats were monitored and urine collections and fatty
acid determinations performed as in study one. Blood was also
obtained at the termination of the experiment for serum albumin,
total protein, cholesterol, triglycerides, urea nitrogen, and creat-
mine determinations.
Study 3. A final investigation was performed to determine the
temporal relationship of the observed fatty acid changes and renal
TXB2 excretion, since the nature of the proposed hypothesis
mandates that increments in urinary TXB2 precede tissue fatty
acid changes. Therefore, male Sprague-Dawley rats were ran-
domly allocated to undergo subtotal nephrectomy (N = 5) or
sham surgery (N = 5) and renal cortical fatty acid composition
was determined four weeks after subtotal nephrectomy. A time
interval of four weeks was chosen since our previous investiga-
tions confirmed the existence of increased renal TXB2 excretion
as early as two weeks following subtotal renal ablation.
Preparation of nephrectomized rats
Briefly, rats were anesthetized with an intraperitoneal injection
of sodium pentobarbital (Nembutal®), Under anesthesia, the left
kidney was exposed with blunt dissection, and 2/3 infarcted by
ligating branches of the renal artery. The right kidney was tied off
and removed. After a thorough check for bleeding, the subcuta-
neous tissue was closed followed by a blind-stitch to the inner
layer of the skin.
Mini-osmotic pumps were loaded with either vehicle (saline) or
U-63557A (0.5 pi/hr) and implanted at the time of surgery via a
subcutaneous pocket created on the dorsum of each rat. Pump
performance necessitated replacement every two weeks through-
out the experimental period.
Tissue fatty acid detenninations
The fatty acid composition of renal cortical tissue was deter-
mined as previously described [3]. Briefly, one-half gram of fresh
or frozen tissue was placed in 5 ml of preheated (90 to 95°C)
dilute (0.02 N) acetic acid and heated for 30 minutes, homoge-
nized, and then centrifuged at 12,000 rpm for 15 minutes at 0°C.
The pellet was washed with 5 ml of dilute acetic acid. The lipid
was extracted from the pellet by rehomogenizing in chloroform!
methanol (1:1, vol/vol) and centrifuging at 3,000 rpm for five
minutes. The pellet was re-extracted with chloroform/methanol
(1:1, vol/vol) and centrifuged. The pellet was then re-extracted a
final time with chloroform/methanol (1:2) and the combined
chloroform extracts were evaporated to dryness and the lipid
dissolved in a known volume of chloroform. An aliquot was
weighed to determine the weight of total lipid extracted. The
methyl esters of the phospholipid and triacylglycerol fractions
were synthesized using hexane.
The fatty acid methyl esters were analyzed on a Varian Model
3500 capillary gas chromatograph equipped with a flame ioniza-
tion detector and a 30 meter capillary column (Supelcowax 10,
Supelco, Inc., Bellefonte, Pennsylvania, USA). The column tem-
perature was programmed from 200°C to 225°C at 1.5°C/mm
increments with a final hold of 17 minutes. Fatty acid standards
were obtained from Supelcowax (PUFA 1, PUFA 2, Supelco Inc.)
Renal histology
Renal tissue from rats was examined in a blinded manner using
light microscopy (400x). Coronal sections were fixed in Zenker's
solution, embedded in paraffin, and stained with periodic acid
Schiff (PAS) and Masson's trichrome stain. Tissue was examined
to determine percentage of glomerulosclerosis and glomerular
areas.
Glomerulosclerosis was characterized by global or segmental
areas where capillaries were collapsed and replaced by PAS-
positive material. The number of any glomeruli with any degree of
segmental or global sclerosis was divided by the total number of
glomeruli to determine the percentage of sclerotic glomeruli. A
minimum of 100 glomeruli were examined for each tissue speci-
men.
Glomerular areas were measured using a point counting
method [13]. For each tissue specimen, 25 glomeruli encountered
on a serpentine course between cortex and medulla were evalu-
ated with a 100 point, calibrated, grid. The area of each glomer-
ular cross-section was determined by multiplying the fraction of
the points from the 100 point grid falling on the glomerular tuft by
the area associated with each point. The glomerular area for each
specimen was calculated as the mean of 25 individual measure-
ments.
Prostaglandin determinations
Specific antibody to PGE2 and TXB2 (stable metabolite of
TXA2) was utilized to determine prostaglandin concentrations in
urine. The antisera for these studies (Cayman Biologicals, Ann
Arbor, Michigan, USA) has <0.02% cross reactivity with other
dienoic prostanoid metabolites. The enzyme immunoassay (EIA)
system employed for these studies has excellent correlation (r2
0.99) with gas chromatography/mass spectrometry as previously
described [14].
Urine aliquots (3 ml) for the determination of PGE2 and TXB2
were acidified to pH 3 to 3.5 with 0.1 N HCI acid and then passed
through an octadecylsilica C18 column which had been activated
with 10 ml methanol and washed with 10 ml water. The sample
was then eluted with 10 ml of water, followed by 10 ml n-hexane
and 10 ml ethylacetate. The ethylacetate fraction was taken to
dryness under nitrogen, reconstituted with 0.5 ml EIA buffer and
then subjected to EIA. Individual measurements of PGE2 and
TXB2 were corrected for percent recoverability by adding a
known quantity of 3H-PGE2 or 3H-TXB2 to the urine samples.
Recovery ranged from 50 to 70%.
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Urinaty albumin excretion and serum chemistries
Twenty-four hour urine collections were made with rats indi-
vidually housed in metabolic cages. The urinary albumin concen-
tration was determined utilizing an enzyme-linked immunoassay
system. (Exocell, mc, Philadelphia, Pennsylvania, USA).
Serum chemistries were performed colorimetrically using an
autoanalyzer (Multistat III +, Instrumentation Laboratories, Lex-
ington, Massachusetts, USA) as previously described [3].
Statistics
Data are expressed as the mean the standard error of the
mean. All variables were screened using indices of kurtosis and
skewness to determine whether the distribution was approxi-
mately Gaussian. When the mean of two groups was compared
the Student's t-test was employed. A simple linear regression
model was utilized to calculate the relationship of specific fatty
acids to prostaglandin and urine albumin excretion. When the
mean of three groups was compared ANOVA was employed,
followed by the Bonferroni-Dunn multiple comparison proce-
dure. All statistical analyses were performed on a MacIntosh Ilci
computer using the SYSTAT statistical software package.
Results
Study I
Body weights obtained prior to surgery were similar in control
(234 2.0 g) and nephrectomized rats (235 2.0 g). Although,
body weights were greater in the control rats (400 8.7 g vs. 324
27.7 g) at the end of the experiment, sustained linear growth
occurred in both groups. Three weeks after surgery, nephrecto-
mized rats had significantly higher albumin excretion rates as
compared to control rats (28.6 10.2 mg/day vs. 2.0 1.5 mg/day,
P < 0.05). The rise in albumin excretion increased in nephrecto-
mized rats achieving a maximum of 74 10.1 mg/day at the
completion of the study. In contrast, albumin excretion in control
rats averaged 3.7 1.7 mg/day at the end of the experimental
period. The incidence of glomerulosclerosis was also greater in
rats subjected to subtotal nephrectomy (4.8 1.8% vs. 0.4
0.1%) as compared to control rats. Glomerular enlargement was
also detected in rats subjected to renal ablation (11391 1074
as compared to control rats (5398 326 m2).
TXB2 excretion was significantly greater in nephrectomized
(28.5 1.1 ng/day) versus control rats (17.6 1.6 ng/day, P <
0.001) six weeks after surgery when expressed as an absolute value
(Fig. 1), This effect was amplified when TXB2 excretion was
corrected for kidney weight (KW). The latter phenomenon was
particularly striking when analyzed at the termination of the
experiment (30.1 8.1 ng/g-KW/day vs. 9.3 1.4 ng/g-KW/day in
control rats). In addition, TXB excretion correlated with the
magnitude of albuminuria in all rats (r2 0.62, P < 0.05). In
contrast, PGE2 excretion did not reach statistically higher values
than those observed in control rats (Fig. 1). Even when corrected
for renal mass, PGE2 excretion was similar in nephrectomized
(20.1 6.8 ng/g-KW/day) and control rats (10.9 2.7 ng/g-KW/
day) and remained significantly less than the corresponding
excretion of TXB2. Thus, these results suggest a relative excess of
TXA2 in rats with severe renal ablation.
Importantly, compositional changes in cortical fatty acids were
observed in aging rats with reduced renal mass (Fig. 2). Specifi-
cally, several complex fatty acids (such as fatty acids with chain
Time, weeks
Fig. 1. TXB2 excretion in rats with renal ablation (0) and control rats (0).
PGE2 excretion in rats with renal ablation () and control rats (S). <
0.05 vs. control rats.
lengths >16 carbons and/or unsaturated fatty acids) were signif-
icantly altered. Stearic acid (18:0) was less abundant in the renal
cortex of rats following renal ablation (13.9 0.7% reduction)
relative to control rats. Interestingly, oleic acid (18:1, n-9) was 44
14.3% higher in the cortex of nephrectomized rats as compared
to control rats. The essential fatty acids, linoleate (18:2, n-6) and
arachidonate (20:4, n-6), were significantly lower in the renal
cortex of rats with ablative renal injury (20.0 1.0 and 10.6
1.1% reduced, respectively) as compared to control rats. The
concentration of both linoleic and arachidonic acid inversely
correlated with the urinary excretion of TXB2 (Fig. 3). This was
specific to TXB2 since it did not occur with PGE2. Collectively,
these findings suggest that TXA2 progenitor fatty acids are
depleted during the course of ablative renal injury. In addition,
the relative increase in oleic acid and decrease in stearic acid may
be coupled to n-6 long chain fatty acid depletion [15j. Interest-
ingly, an inverse correlation between renal albuminuria and the
concentration of cortical linoleic and stearic acid was observed (r2
= 0.69 and 0.73, respectively). In contrast, no correlation between
renal PGE2 synthesis, albuminuria and cortical fatty acids was
observed.
Study 2
Body weights obtained prior to surgery were similar in control
(234 2.0 g), nephrectomized (235 2.0 g), and rats treated with
U-63557A (234 9.9 g). Although body weights were greater in
the control rats (400 8.7 g) and rats treated with U-63557A (370
26 g, P < 0.01), than untreated nephrectomized rats (357 27
g) at the end of the experiment, food intakes and growth curves
were similar in each group. While untreated nephrectomized rats
were severely albuminuric throughout the experimental period,
rats treated with U-63557A had a significant reduction in albumin
excretion (Fig. 4). Albuminuria increased in nephrectomized rats
achieving a maximum of 69 8.1 mg/day at the termination of the
experiment. In contrast, albuminuria in control rats remained less
than 5 mg/day throughout the experimental period. Importantly,
rats treated with U-63557A had urinary albumin excretion rates
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Fig. 2. Fatty acid composition of rats with renal
ablation 9 weeks after subtotal nephrectomy.
Open bars represent the percent change from
control rats. 16:0, palmitic acid; 18:0, stearic
acid; 18:1 (n-9), oleic acid; 18:2 (n-6)
linoleic acid; 20:4 (n-6), arachidonic acid; 20:5
(n-3), eicosapentaenoic acid; 22:5 (n-3),
docosapentaenoic acid; 22:6 (n-3),
docosahexaenoic acid. *D < 0.05.
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which were similar to those observed in control rats (Fig. 4). The
incidence of glomeruloscierosis was significantly greater in rats
subjected to subtotal nephrectomy (9.2 1.0%) as compared to
control rats (0.3 0.1%) or nephrectomized rats treated with
Time, weeks
Fig. 4. Twenty-four hour urinaty albumin excretion (UV) in control rats
(A), rats with renal ablation (0), and rats treated with U-63557A (El). *P <
0.01 vs. other groups.
U-63557A (1.0 0.3%). Glomerular enlargement was also ob-
served in rats subjected to renal ablation (10488 1221 m2) as
compared to control rats (6208 406 m2, P < 0.01) or rats treated
with U-63557A (8089 678 m2). Serum cholesterol, triglycerides,
BUN and creatinine were similarly increased nine weeks after
renal ablation as compared to control rats or rats treated with
U-63557A (Table 1). A significant decrement in serum albumin
and total serum protein was also observed in rats with renal
ablation. The latter changes were presumed secondary to a
combination of renal injury and severe nephrotic syndrome.
Compositional changes in cortical fatty acids were noted in
aging rats with reduced renal mass which paralleled those ob-
served in study one (Fig. 5). Thus, a 13.0 0.6% reduction in
stearic acid and a 48.2 10.6% increase in oleic acid was
V
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observed in nephrectomized rats. Importantly, TXA2 progenitor
fatty acids, linoleic and arachidonic acid, were reduced by 22.3
1.3% and 20.9 1.7%, respectively.
As anticipated U-63557A resulted in a significant attenuation of
TXB2 excretion in rats with renal ablation (Fig. 6). Indeed, TXB2
excretion was similar to that observed in control rats. Importantly,
normalization of TXB2 excretion in U-63557A treated rats was
associated with amelioration of the renal cortical fatty acid
composition (Fig. 5). Arachidonic acid and linoleic acid concen-
trations approached those observed in control rats (P C 0.001).
Moreover, U-63557A improved oleic acid concentration (P
0.08) and normalized stearic acid concentration (P C 0.05). Thus,
the entire constellation of fatty acid changes observed in nephrec-
tomized rats was largely attenuated by treatment with U-63557A.
In particular, U-63557A resulted in a striking improvement in the
relative concentration of fatty acids which are progenitors for
endogenous TXA2 synthesis (Fig. 7). In contrast, POE2 excretion
was unaffected by treatment with U-63557A (Fig. 8).
Study 3
Renal cortical fatty acid composition was similar in control and
remnant kidneys four weeks after renal ablation (Fig. 9). Since
renal injury in the remnant kidney is invariably present two to
three weeks post-nephrectomy, these results suggest that tissue
fatty acid changes are not necessary for the initiation of renal
injury in nephrectomized rats. In addition, a 75% increase in renal
TXB2 excretion was noted at this time (Fig. 9, inset). Thus,
enhanced urinary TXB2 excretion precedes cortical fatty acid
changes and thus, in conjunction with the findings presented in
study one supports the hypothesis that the fatty acid profiles in
aging nephrectomized rats are a consequence rather than a cause
of increased renal TXA2 synthesis.
Table 1. Laboratory data of control rats, rats subjected to ¾
nephrectomy (Nx), and nephrectomized rats treated with U-63557A
Serum chemistries Control /6 Nx U-63557A
Chol mgldl 78.7 3.1 219.7 11.2" 88.6 6.3
TO mg/dl 69.6 5.0 138.7 18.9" 78.4 4.4
BUN mg/dl 22.6 0.8 90.2 7.58" 30.1 3.1
Cr mg/dl 0.48 0.0 1.9 0.1" 0.61 0.1
AIb glliter 3.09 0.3 2.39 0.1" 3.01 0.1
TSP glliter 6,01 0.1 5.20 0.2" 5.94 0.1
Abbreviations are: chol, cholesterol; TO, triglycerides; BUN, blood urea
nitrogen; Cr, creatinine; AIb, albumin; TSP, total serum protein.
"P C 0.05 vs. other groups
Discussion
Essential fatty acid deficiency has been described in a variety of
clinical settings (altered precursor intake, gastrointestinal fat
malabsorption, and hepatic disease) [15], but only recently has
this phenomenon been reported in progressive glomerular injury
[4—61. Moreover, the mechanisms responsible for abnormal renal
cortical fatty acid composition in the injured kidney are incom-
pletely understood. We hypothesized that increased endogenous
eicosanoid turnover, occurring as a consequence of ablative renal
injury, eventuates in the depletion of eicosanoid progenitor fatty
acids which, in turn, obligates corresponding changes in other
long chain fatty acids.
Although, recent studies in diverse experimental models of
progressive glomerulosclerosis have demonstrated abnormal tis-
sue fatty composition [3, 5], studies of tissue lipid composition in
the remnant model of renal injury had not been performed. Thus,
an important finding in the present investigation was the detection
of abnormalities in the renal cortical fatty acid profile of remnant
kidneys with advancing renal disease. A similar, relative essential
fatty acid deficiency has been described in rats with diabetes and
uninephrectomized rats fed diets enriched with cholesterol [4, 5].
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Fig. 5. Fatty acid composition of untreated rats
(LI) and U-63557A treated rats () with renal
ablation 9 weeks after surgery. Bars represent the
percent change from control rats. 16:0, palmitic
acid; 18:0, stearic acid; 18:1 (n-9), oleic acid;
18:2 (n-6) linoleic acid; 20:4 (n-6), arachidonic
acid; 20:5 (n-3), eicosapentaenoic acid; 22:5
(n-3), docosapentaenoic acid; 22:6 (n-3),
docosahexaenoic acid. * < 0.05 vs. control
rats; tP c 0.05 vs. untreated rats with renal
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Fig. 8. PGE2 excretion in control rats (0) versus untreated rats (D) or
U-63557A treated rats (V) with renal ablation.
In previous reports, serum lipid disturbances were felt to initiate
glomerular injury since abnormalities in circulating lipids ante-
dated glomerular injury. However, the tissue lipid changes were
examined well after the establishment of renal injury and thus, the
relationship of tissue lipid alterations to circulating lipids or the
initiation of progressive renal injury was uncertain. Interestingly,
abnormalities in the cortical fatty acid composition were not
detected in our study when examined within four weeks of renal
ablation. This suggests that the initiation of renal injury in the
remnant kidney is not dependent on tissue fatty acid changes and
that renal cortical fatty acid changes are a consequence rather
than a cause of renal injury. This does not necessarily exclude
subsequent potentiation of injury via coincident tissue fatty acid
changes since, the concentration of linoleic and stearic acid
inversely correlated with albuminuria.
Importantly, the dienoic prostaglandin progenitor fatty acids,
linoleic and arachidonic acid, were reduced in rats with renal
ablation. Moreover, the concentration of prostaglandin progeni-
tors inversely correlated with renal TXB2 excretion. The latter
observation supports the hypothesis that changes in tissue fatty
acid composition are biochemically linked to deranged renal
prostaglandin metabolism, specifically increased TXA2 synthesis.
Furthermore, a rise in renal TXB2 excretion preceded the tissue
fatty acid changes by several weeks, suggesting that accelerated
fatty acid turnover is responsible for essential fatty acid depletion.
To further elucidate the relationship of enhanced renal TXA2
synthesis and essential fatty acid depletion, the specific TXA2
synthase antagonist, U-63557A, was administered to rats with
renal ablation. Chronic subcutaneous administration of U-63557A
resulted in a decrement in urinary TXB2 excretion and a slight
increase in PGE2. Preservation of both linoleic and arachidonic
acid was observed in nephrectomized rats treated with U-63557A.
Moreover, the preservation of TXA2 progenitor fatty acids oc-
curred in conjunction with a decline in TXB2 excretion.
An increase in oleic acid concentration was also noted in rats
with advancing renal disease. Recently, the ratio of oleic acid to
linoleic acid has been shown to correlate with renal structural
damage [3]. In addition, several studies have demonstrated that
oleic acid can alter cell function through activation of intracellular
signalling pathways [16]. Whether the increase in oleic acid is a
compensatory response to diminished cortical polyunsaturated
fatty acid concentration or a primary response to nephron abla-
tion is unknown. Nonetheless, the rise in oleate concentration was
partially attenuated following the administration of U-63557A,
which suggests that the oleic acid concentration may be coupled to
endogenous turnover of linoleic and arachidonic acid. Such a
phenomenon would be in accord with previous studies examining
membrane fatty acid homeostasis [17]. The decline in stearic acid
concentration detected in rats with renal ablation was likely
coupled to the rise in oleic acid concentration since stearic acid is
the progenitor for oleic acid synthesis. Since U-63557A also
preserved the stearic acid concentration of remnant kidneys it is
reasonable to attribute the ancillary fatty acid changes detected in
remnant kidneys to depletion of TXA2 precursor fatty acids.
Although, other studies have examined prostaglandin excretion
at different time intervals following renal ablation, no study has
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examined this phenomenon in a serial fashion. The present study
confirms the suggestion that TXB2 excretion remains elevated for
up to 50 days following subtotal nephrectomy. However, the
increment in TXB2 excretion appeared to plateau as rats with
subtotal nephrectomy aged (Fig. 6). Since the availability of
arachidonic acid is thought to represent the rate limiting step in
the synthesis of renal eicosanoids, an apparent plateau in TXB2
excretion may be secondary to limitation of precursor supply. In
contrast, PGE2 excretion remained significantly lower than the
corresponding TXB2 excretion and at no time reached statistically
higher values than control rats. These results were surprising in
view of the fact that both TXA2 and PGE2 are derived from
arachidonic acid and suggests distinct regulation of TXA2 and
PGE2 synthase. Since TXA2 synthase and POE2 synthase are
unique enzymes, such independent regulation is believed to exist
[181. Moreover, similar imbalances in vasodilator and vasocon-
strictor prostaglandin synthetic rates have been noted in diabetic
nephropathy [19], hepatorenal syndrome [20] and immune-medi-
ated glomerular diseases [21]. Recent investigations have sug-
gested that angiotensin II may stimulate, and thus regulate TXA2
synthase activity [22]. Therefore, a relative excess of angiotensin II
activity may give rise to selective stimulation of TXA2 synthase.
The source of the increased renal TXB2 excretion cannot be
answered by the present study although, under normal circum-
stances little TXA2 is generated by isolated glomeruli, tubules or
interstitial cells. Intrarenal aggregation of platelets is unlikely to
be a major source of TXB2 excretion [23]. The possibility that
renal ablation leads to an adaptive increase in glomerular, tubular
or interstitial cell prostaglandin synthesis has also been investi-
gated [8]. In addition, infiltrating inflammatory cells may contrib-
ute to enhanced TXB2 excretion after experimental renal injury
[24].
Administration of U-63557A significantly attenuated renal in-
jury in rats with renal ablation, These findings are in agreement
with other investigations examining the use of thromboxane
synthase inhibitors in progressive renal injury [10, 25]. Both
hemodynamic and nonhemodynamic factors have been postulated
to underlie the harmful effects of TXA2 in progressive renal
injury.
1190 Schmitz et al: Fatly acids and thromboxane synthase
80
::
,—
40
Control Nx
20
0
20
I
16:0
18:0
•
—I I
18:1(n-9)
18:2(n6)
' '
20:4(n-6) 20:5(n.3) 22:5(n.3)
22:6(n-3)
Fig. 9. Fatly acid composition of rats with renal
ablation four weeks after subtotal nephrectomy.
Open bars represent the percent change from
—4o
—60
control rats. 16:0, palmitic acid; 18:0, stearic
acid; 18:1 (n-9), oleic acid; 18:2 (n-6) linoleic
acid; 20:4 (n-6), arachidonic acid; 20:5
(n-3), eicosapentaenoic acid; 22:5 (n-3),
docosapentaenoic acid; 22:6 (n-3),
—8o docosahexaenoic acid. Inset—Urinary TXB2
excretion in control rats or rats with renal
ablation (Nx) four weeks after surgery.
—100 0.05.
Renal ablation
1
prostaglandin
synthase
Depletion of TXA2
progenitor fatty acids
20:4 (n-6)
ci)) cci
0) =C2 cci
18:2 (n-6)
18:0
'if
18:0
cisA9 A
18:1(n-9)
desaturase
Fig. 10. Proposed model depicting the effects of increased renal TXA2
synthesis on cortical fatly acid composition. 18:0, stearic acid; 18:1 (n-9),
oleic acid; 18:2 (n-6), linoleic acid; 20:4 (n-6), arachidonic acid.
Schmitz et a!: Fatly acids and thromboxane ynthase 1191
In summary, we have demonstrated significant disturbances in
renal cortical fatty acid composition in nephrectomized rats with
advancing renal disease. The most striking abnormalities con-
sisted of a fall in linoleic, arachidonic and stearic acid concentra-
tion and a rise in oleic acid concentration. This contrasted with
the relatively well preserved fatty acid profile of rats studied
within four weeks of renal ablation. The inverse correlation
between progenitor fatty acid concentration and renal TXB2
excretion suggested that these biological events are coupled to
one another. Importantly, chronic administration of U-63557A
corrected the essential fatty acid depleted state in remnant
kidneys providing convincing support for the proposed hypothesis.
In addition, the ancillary fatty acid changes observed in this study
were ameliorated by treatment with U-63557A. The latter obser-
vation suggests that increased synthesis of TXA2 leads to a
succession of events culminating in compensatory changes in
other long chain fatty acids such as oleic and stearic acid (Fig. 10).
Thus, we believe that the remnant kidney represents a newly
described cause of acquired essential fatty acid depletion second-
ary to augmented renal TXA2 synthesis. Extrapolation of these
findings to other experimental models of renal injury or to
humans is tempting since an increase in renal TXA2 synthesis is a
frequently cited phenomenon in the injured kidney.
Acknowledgments
Portions of this manuscript were published in abstract form (JAm Soc
Nephrol 2:690, 1991). The authors acknowledge the Upjohn Company
(Kalamazoo, Michigan, USA) for the kind gift of U-63557A. The authors
are grateful to Dr. Kevin Martin (St. Louis, Missouri, USA) for his critical
review of the manuscript.
Reprint requests to Paul G. Schmitz, M.D., St. Louis University Health
Sciences Center, Division of Nephrology, 3635 Vista Avenue, St. Louis,
Missouri 63110, USA.
References
1. KLAHR 5, SCHREINER G, ICHIKAWA I: The progression of renal disease.
NEngIJ Med 318:1657—1666, 1988
2. SCHMITZ PG, KAsIsKE BL, O'DONNELL MP, KEANE WF: Lipids and
progressive renal injury. Semin Nephrol 9:354—69, 1989
3. K.sisiu BL, O'DONNELL MP, SCHMITZ PG, KIM Y, KEANE WF: Renal
injury of diet-induced hypercholesterolemia in rats. Kidney mt 37:880—
891, 1990
4. HOLMAN RT, JOHNSON SB, GERRARD JM, MAUER SM, KuPcHo-
SANDBERG 5, BROWN DM: Arachidonic acid deficiency in streptozo-
tocin-induced diabetes. Proc Nat! Acad Sci USA 80:2375—2379, 1983
5. KASISKE BL, O'DONNELL MP, CLEARY MP, KEANE WF: Effects of
reduced renal mass on tissue lipids and renal injury in hyperlipidemic
rats. Kidney mt 35:40—47, 1989
6. BARCELLI UO, WEISS M, BEACH D, MOTZ A, THOMPSON B: High
linoleic acid diets ameliorate diabetic nephropathy in rats. Am J
Kidney Dis 16:244—251, 1990
7. HIGGS G: The effects dietary intake of essential fatty acids on
prostaglandin and leukotriene synthesis. Proc Nuir Soc 44:181—187,
1985
8. STAHL R, KUDELKA S, PARAvIcINI M, SCH0LLMEYER P: Prostaglandin
and thromboxane formation in glomeruli from rats with reduced renal
mass. Nephron 42:252—257, 1986
9. JOHNSON R, NIDY E, AIKEN J, CRITFENDEN N, GORMAN R: Throm-
boxane A2 synthase inhibitors. J Med Chem 29:1461—1468, 1986
10. PURKERSON M, JoisT JH, YAms J, VALDES A, MORRISON A, KLAHR5:
Inhibition of thromboxane synthesis ameliorates the progressive kid-
ney disease of rats with subtotal renal ablation. Proc Nat! Acad Sci
USA 82:193—197, 1985
11. FITZGERALD D, FRAGETFA J, FENELON L, FITZGERALD G: Thrombox-
ane synthase inhibition and thromboxane/endoperoxide receptor an-
tagonism in a chronic canine model of coronary thrombosis. Adv Prost
Thromb Leuk Res 17A:496—500, 1987
12. LAKINGS D, FRIIs J: Liquid chromatographic-ultraviolet methods for
furegrelate in serum and urine: Preliminary pharmacokinetic evalua-
tion in the dog. J Pharm Sci 74:455—459, 1985
13. LANE PH, STEFFES MW, MAUER SM: Estimation of glomerular
volume: A comparison of four methods. Kidney mt 41:1085—1089,
1992
14. WESTCOTF JY: Analysis of 6-keto PGF1a, 5-HETE, and LTC4 in rat
lung: Comparison of GM/MS, RIA, and EIA. Prostaglandins 32:857—
873, 1986
15. HOLMAN RT: Control of polyunsaturated acids in tissue lipids. JAm
Co/I Nutr 5:183—211, 1986
16. KHAN WA, BLOBE GC, HANNUN YA: Activation of protein kinase C
by oleic acid. Determination and analysis of inhibition by detergent
micelles and physiologic membranes: requirement for free oleate. J
Biol Chem 267:3605—3612, 1992
17. STUBBS C, SMITh A: The modification of mammalian membrane
polyunsaturated fatty acid composition in relation to membrane
fluidity and function. Biochim Biophys Acta 774:89—137, 1984
18. SMI'm WL, MARNETr Li, DEwIrr DL: Prostaglandin and thrombox-
ane biosynthesis. Pharmac Ther 49:153—179, 1991
19. GERRARD JM, STUART MJ, Rko GHR, Smrrus MW, MAUER SM,
BROWN DM, WHITE JO: Alteration in the balance of prostaglandin
and thromboxane synthesis in diabetic rats. J Lab Clin Med 95:950—
958, 1980
20. GOVINDARAJAN5, NAST CC, SMrnI WL, KOYLE MA, DASKALOPOULOS
G, ZIPSER RD: Immunohistochemical distribution of renal prostag-
landin endoperoxide synthase and prostacyclin synthase: Diminished
endoperoxide synthase in the hepatorenal syndrome. Hepatology
7:654—659, 1987
21. KELLEY yE, SNEVE 5, MUSINSKI 5: Increased renal thromboxane
production in murine lupus nephritis. J C/in Invest 77:252—258, 1986
22. WILcox CS, WELCHWJ, SNELLEN H: Thromboxane mediates renal
hemodynamic response to infused angiotensin II. Kidney mt 40:1090—
1097, 1991
23. ZOJA C, BENIGNI A, LIvIo M: Selective inhibition of platelet throm-
boxane generation with low-dose aspirin does not protect rats with
reduced renal mass from the development of progressive disease. Am
JPathol 134:1027—1038, 1989
24. SCHREINER GF, ROVIN B, LEFKOWITH JB: The antiinflamatory effects
of essential fatty acid deficiency in experimental glomerulonephritis:
Modulation of macrophage migration and eicosanoid metabolism. J
Immunol 143:3192—3195, 1989
25. ZOJA C, PERICO N, CORNA D, BENIGNI A, GABANELLI M, MORIGI M,
BERTANI T, REMUZZI G: Thromboxane synthesis inhibition increases
renal prostacyclin and prevents renal disease progression in rats with
remnant kidney. JAm Soc Nephrol 1:799—807, 1990
